Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 2.170 | 1.88% | 0.040 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.00% | |
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | 1.88% | |
Narrow Range Bar | Range Contraction | 1.88% | |
Stochastic Reached Oversold | Weakness | 1.88% |
Get a Trading Sidekick!
- Earnings date: 2024-02-01
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Infrastructure Healthcare Pipe Pharma Pharmaceutical Pipeline Integrated Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.53 |
52 Week Low | 1.44 |
Average Volume | 43,729 |
200-Day Moving Average | 1.909 |
50-Day Moving Average | 1.863 |
20-Day Moving Average | 2.206 |
10-Day Moving Average | 2.230 |
Average True Range | 0.105 |
RSI (14) | 55.16 |
ADX | 26.59 |
+DI | 24.849 |
-DI | 22.231 |
Chandelier Exit (Long, 3 ATRs) | 2.285 |
Chandelier Exit (Short, 3 ATRs) | 1.985 |
Upper Bollinger Bands | 2.552 |
Lower Bollinger Band | 1.859 |
Percent B (%b) | 0.45 |
BandWidth | 31.449 |
MACD Line | 0.096 |
MACD Signal Line | 0.130 |
MACD Histogram | -0.0342 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.305 | ||||
Resistance 3 (R3) | 2.297 | 2.243 | 2.283 | ||
Resistance 2 (R2) | 2.243 | 2.209 | 2.248 | 2.275 | |
Resistance 1 (R1) | 2.207 | 2.188 | 2.180 | 2.215 | 2.267 |
Pivot Point | 2.153 | 2.153 | 2.140 | 2.158 | 2.153 |
Support 1 (S1) | 2.117 | 2.119 | 2.090 | 2.125 | 2.073 |
Support 2 (S2) | 2.063 | 2.098 | 2.068 | 2.065 | |
Support 3 (S3) | 2.027 | 2.063 | 2.058 | ||
Support 4 (S4) | 2.035 |